These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5898429)

  • 1. [A low molecular weight plasma expander: hemagel (clinico-experimental study)].
    Baldassarre M
    Acta Anaesthesiol; 1965; 16(6):817-31. PubMed ID: 5898429
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study on modified fluid gelatin as a serum volume expander].
    Murakami S; Hamabe N; Kitani M; Ota Y; Tanigawa H
    Masui; 1969 Jun; 18(6):500-9. PubMed ID: 5816994
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of the gelatin expander physiogel on kidney function].
    Cottier P; Basevi A; Schafroth HJ
    Helv Chir Acta; 1966 May; 33(3):383-91. PubMed ID: 5994658
    [No Abstract]   [Full Text] [Related]  

  • 4. [BLOOD TYPING AND THE USE OF A NEW PLASMA EXPANDER: HEMAGEL].
    ANDREUCCI S
    Minerva Anestesiol; 1963 Sep; 29():342-7. PubMed ID: 14093107
    [No Abstract]   [Full Text] [Related]  

  • 5. [A plasma-expander with a gelatine base and its effect on blood coagulation, fibrinolysis and function of thrombocytes].
    Fischer M
    Arzneimittelforschung; 1967 Sep; 17(9):1129-31. PubMed ID: 5632285
    [No Abstract]   [Full Text] [Related]  

  • 6. [Functional and histological studies of the effect of a modified high molecular weight gelatin preparation on the kidneys].
    Hölscher B
    Chirurg; 1968 May; 39(5):228-30. PubMed ID: 5715439
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation studies on oxypolygelatin and degraded gelatin as plasma volume expanders.
    Gabr YA; Assem NM; Micheal AB; Fahmy LH
    Arzneimittelforschung; 1996 Aug; 46(8):763-6. PubMed ID: 9125275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some aspects of blood coagulation after treatment with Hemagel: in vitro heparin tolerance test and fibrinolysis].
    Balestra L; Mereto GC
    Minerva Anestesiol; 1965 Sep; 31(9):418-20. PubMed ID: 5854635
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient proteinuria after infusion of a gelatin plasma volume expander.
    Ambühl PA; Müller V; Binswanger U
    Clin Nephrol; 1999 Dec; 52(6):399-400. PubMed ID: 10604652
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects.
    de Jonge E; Levi M; Berends F; van der Ende AE; ten Cate JW; Stoutenbeek CP
    Thromb Haemost; 1998 Feb; 79(2):286-90. PubMed ID: 9493577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
    Thaler U; Deusch E; Kozek-Langenecker SA
    Anaesthesia; 2005 Jun; 60(6):554-9. PubMed ID: 15918826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative histologic investigations on the effect of repeated intravenous injections of large quantities of isogenous blood plasma and Physiogel in mice].
    Cottier H
    Helv Chir Acta; 1966 May; 33(3):376-82. PubMed ID: 5994657
    [No Abstract]   [Full Text] [Related]  

  • 13. The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption.
    ten Dam MA; Branten AJ; Klasen IS; Wetzels JF
    J Crit Care; 2001 Sep; 16(3):115-20. PubMed ID: 11689768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic hemodynamics and oxygen supply to the body in moderate and severe hemodilution induced by gelatinol].
    Kolonina IR
    Patol Fiziol Eksp Ter; 1980; (1):83-4. PubMed ID: 7375168
    [No Abstract]   [Full Text] [Related]  

  • 15. [CLINICAL CONSIDERATIONS ON THE USE OF A NEW COLLOIDAL PLASMA EXPANDER (HEMAGEL)].
    BIGNOTTI N; TONINELLI P; TONOLINI U
    Riv Patol Clin; 1964 Nov; 19():693-714. PubMed ID: 14284049
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach.
    Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P
    Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the properties of gelatin on the quality of solution of the plasma substitute gelatinol].
    Chuprasov VK; Znamenskaia TV; Radkevich D
    Probl Gematol Pereliv Krovi; 1978 Jan; 23(1):53-5. PubMed ID: 628669
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular changes associated with epidural anesthesia and the infusion of plasma expander].
    Sakamoto A
    Masui; 1986 Feb; 35(2):265-76. PubMed ID: 3702045
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of the anti-inflammatory effects of hydroxyethyl starch demonstrated in a flow-based model of neutrophil recruitment by endothelial cells.
    Matharu NM; Butler LM; Rainger GE; Gosling P; Vohra RK; Nash GB
    Crit Care Med; 2008 May; 36(5):1536-42. PubMed ID: 18434912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation studies on a 4 per cent gelatin solution containing 1 per cent glycine for intravenous use.
    Gabr Y; Saleeb F; Osman M
    Arzneimittelforschung; 1967 May; 17(5):643-5. PubMed ID: 5631598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.